The crosstalk between thyroid hormones and the Renin-Angiotensin System (Q37621652)

21 August 2017

1 reference

title

The crosstalk between thyroid hormones and the Renin-Angiotensin System (English)

1 reference

21 August 2017

author name string

Maria Luiza M Barreto-Chaves

1

1 reference

21 August 2017

Maria Alícia Carrillo-Sepúlveda

2

1 reference

21 August 2017

Marcela S Carneiro-Ramos

3

1 reference

21 August 2017

Dayane A Gomes

4

1 reference

21 August 2017

Gabriela P Diniz

5

1 reference

21 August 2017

publication date

24 October 2009

1 reference

21 August 2017

published in

Vascular Pharmacology

1 reference

21 August 2017

volume

52

1 reference

21 August 2017

issue

3-4

1 reference

21 August 2017

page(s)

166-170

1 reference

The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Update on tissue renin-angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

The renin-angiotensin system in thyroidectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

The molecular basis of thyroid hormone action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Tissue-specific modulation of angiotensin-converting enzyme (ACE) in hyperthyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone modulates renin and ANG II receptor expression in fetal sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone replacement normalizes renal renin and angiotensin receptor expression in thyroidectomized fetal sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Local renin-angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Nongenomic actions of thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Nongenomic actions of thyroid hormone on the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Tissue angiotensin system in cardiovascular medicine. A paradigm shift?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

The renin-angiotensin system in hypothyroidism of short duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormones and renin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone induction of actin polymerization in somatotrophs of hypothyroid rats: potential repercussions in growth hormone synthesis and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Changes in endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Rapid nongenomic actions of thyroid hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Renin-angiotensin system in hypothyroid rats: effects of potassium iodide and triiodo-L-thyronine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone action in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid disease and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone and the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone treatment after coronary-artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Direct effects of triiodothyronine on human internal mammary artery and saphenous veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

The intracellular renin-angiotensin system: a new paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Rapamycin prevents thyroid hormone-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Reduced serum angiotensin converting enzyme activity in children with congenital hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Renin-angiotensin system in thyroid dysfunction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Angiotensin II (AII) and adrenal gland AII receptors in rats with congenital hypothyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Ontogeny of renal renin in congenital hypothyroid rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Acute effects of triiodothyronine on endothelial function in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Acute effects of thyroid hormone on vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Physiology of local renin-angiotensin systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Cardiac angiotensin receptors in experimental hyperthyroidism in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

Direct effects of thyroid hormones on rat coronary artery: nongenomic effects of triiodothyronine and thyroxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.009

10.1016/J.VPH.2009.10.009

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference